Renal Outcomes With Tenofovir Alafenamide in Liver Transplant Recipients

被引：3
作者：
Liu, Joanne K. [1 ]
Vutien, Philip [2 ]
Huang, Daniel Q. [3 ]
Ishigami, Masatoshi [4 ]
Landis, Charles S. [2 ]
Nguyen, Mindie H. [5 ,6 ]
机构：
[1] Univ Washington, Seattle, WA USA
[2] Hepatol Univ Washington, Div Gastroenterol, Seattle, WA USA
[3] Natl Univ Singapore, Natl Univ Hosp, Yong Loo Lin Sch Med, Div Gastroenterol & Hepatol,Dept Med, Singapore, Singapore
[4] Hepatol Nagoya Univ, Grad Sch Med, Div Gastroenterol, Nagoya, Japan
[5] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Palo Alto, CA USA
[6] Stanford Univ, Med Ctr, 780 Welch Rd, Palo Alto, CA 94304 USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 21卷 / 02期
关键词：
D O I：
10.1016/j.cgh.2022.01.035
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：7
相关论文
共 7 条
  • [1] Tenofovir Alafenamide Fumarate: A New Tenofovir Prodrug for the Treatment of Chronic Hepatitis B Infection
    Buti, Maria
    Riveiro-Barciela, Mar
    Esteban, Rafael
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2017, 216 : S792 - S796
  • [2] Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate
    Kaneko, Shun
    Kurosaki, Masayuki
    Tamaki, Nobuharu
    Itakura, Jun
    Hayashi, Tsuguru
    Kirino, Sakura
    Osawa, Leona
    Watakabe, Keiya
    Okada, Mao
    Wang, Wan
    Shimizu, Takao
    Higuchi, Mayu
    Takaura, Kenta
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Takahashi, Yuka
    Watanabe, Mamoru
    Izumi, Namiki
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (11) : 2004 - 2010
  • [3] Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B
    Ogawa, Eiichi
    Nomura, Hideyuki
    Nakamuta, Makoto
    Furusyo, Norihiro
    Koyanagi, Toshimasa
    Dohmen, Kazufumi
    Ooho, Aritsune
    Satoh, Takeaki
    Kawano, Akira
    Kajiwara, Eiji
    Takahashi, Kazuhiro
    Azuma, Koichi
    Kato, Masaki
    Shimoda, Shinji
    Hayashi, Jun
    [J]. LIVER INTERNATIONAL, 2020, 40 (07) : 1578 - 1589
  • [4] Safety and efficacy of tenofovir alafenamide in liver transplant recipients: A single center experience
    Rashidi-Alavijeh, Jassin
    Straub, Katja
    Achterfeld, Anne
    Wedemeyer, Heiner
    Willuweit, Katharina
    Herzer, Kerstin
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2021, 23 (03)
  • [5] Long-term outcomes with oral therapy in liver transplant recipients with hepatitis B
    Saab, Sammy
    Song, Dana
    Challita, Youssef P.
    Zhou, Tina Xiwen
    Saab, Elena G.
    Viramontes, Matthew R.
    Choi, Gina
    Durazo, Francisco A.
    Han, Steven B.
    El Kabany, Mohammed M.
    Jackson, Nicholas J.
    Busuttil, Ronald W.
    [J]. CLINICAL TRANSPLANTATION, 2019, 33 (12)
  • [6] Potential Benefits of Switching Liver Transplant Recipients to Tenofovir Alafenamide Prophylaxis
    Sripongpun, Pimsiri
    Mannalithara, Ajitha
    Kwo, Paul Y.
    Kim, W. Ray
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (03) : 747 - 749
  • [7] Renal dysfunction in liver transplant recipients: Evaluation of the critical issues
    Weber, Marc L.
    Ibrahim, Hassan N.
    Lake, John R.
    [J]. LIVER TRANSPLANTATION, 2012, 18 (11) : 1290 - 1301
1